FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:273-274 January 25, 1996 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The Centers for Disease Control and Prevention recently noted that rheumatic fever is among 10 diseases that have been removed from the list of nationally notifiable diseases.¹ Although this decision may be appropriate at the national level, it could be dangerous if local health departments adopted the same policy. In the mid-1980s, after more than a decade of the apparent absence of cases of rheumatic fever, numerous surprising outbreaks occurred in a variety of geographic and socioeconomic settings across the United States.² A high percentage of these cases involved carditis.

The prevention of rheumatic fever requires the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Choi, K.-S., Dumler, J. S. (2007). Mitogenic Component in Polar Lipid-Enriched Anaplasma phagocytophilum Membranes. CVI 14: 1260-1265 [Abstract] [Full Text]  
• Choi, K.-S., Webb, T., Oelke, M., Scorpio, D. G., Dumler, J. S. (2007). Differential Innate Immune Cell Activation and Proinflammatory Response in Anaplasma phagocytophilum Infection. Infect. Immun. 75: 3124-3130 [Abstract] [Full Text]  
• DEMMA, L. J., HOLMAN, R. C., MCQUISTON, J. H., KREBS, J. W., SWERDLOW, D. L. (2005). EPIDEMIOLOGY OF HUMAN EHRLICHIOSIS AND ANAPLASMOSIS IN THE UNITED STATES, 2001-2002. Am J Trop Med Hyg 73: 400-409 [Abstract] [Full Text]